Home > Financial Ratios > CIPLA

CIPLA
Core EBITDA Growth

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -15.3313.5327.9013.836.98

What is the latest Core EBITDA Growth ratio of CIPLA ?

The latest Core EBITDA Growth ratio of CIPLA is -15.33 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-15.33
Mar202513.53
Mar202427.90
Mar202313.83
Mar20226.98

How is Core EBITDA Growth of CIPLA Trending?

Years Core EBITDA Growth % Change
Mar2026 -15.33
Negative
Mar2025 13.53
-51.51
Mar2024 27.9
101.74
Mar2023 13.83
98.14
Mar2022 6.98 -

Other Financial Ratios of CIPLA


Compare Core EBITDA Growth ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹118,922.9 Cr 0.2% 2.1% -5.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
MANKIND PHARMA ₹100,730.0 Cr -1.4% -3.7% -5.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

0.2%

2.1%

-5.1%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses